Literature DB >> 2549839

The surgical conservation of the neuropathic foot.

A G Warren1.   

Abstract

Basic surgical principles applied when caring for neuropathic limbs can result in the maintenance or restoration of a useful ulcer-free limb. It is possible to help many patients with neuropathy to become ulcer-free and to remain ulcer-free and mobile, with surgical procedures. Recommended methods of management are briefly outlined. These include the débridement of the osteomyelitic, metatarsal head in order to save the adjacent toe, removal of bony irregularities that predispose to ulceration, and the use of wedge osteotomies and arthrodeses to improve the functional shape of the affected foot. The emphasis is on the removal of high pressure points from the weight-bearing surface and to increase the total area available for weight-bearing. Adequate rest and protection are essential, and include the use of splints or total contact plaster casts in all cases of ulceration of weight-bearing surfaces. All patients with reduced sensory perception should learn daily self-examination and care to reduce the chances of recurrent ulceration. Healing after surgical reconstruction will occur, and the healed tissues, if adequately cared for, will maintain their integrity for years.

Entities:  

Mesh:

Year:  1989        PMID: 2549839      PMCID: PMC2498986     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  1 in total

1.  Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment.

Authors:  J T Johnson
Journal:  J Bone Joint Surg Am       Date:  1967-01       Impact factor: 5.284

  1 in total
  2 in total

Review 1.  Neurology and orthopaedics.

Authors:  Henry Houlden; Paul Charlton; Dishan Singh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03       Impact factor: 10.154

2.  Conservative amputation of the neuropathic foot- The Pirogoff procedure.

Authors:  G Warren
Journal:  Oper Orthop Traumatol       Date:  1997-03       Impact factor: 1.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.